Squaric Acid Dibutyl Ester

DRUG4 trials

Sponsors

Squarex, LLC, Massachusetts General Hospital, Wei-Che Ko

Conditions

Allergic Contact DermatitisCongenital Melanocytic NevusHSVHerpes LabialisSkin Inflammation

Early Phase 1

SADBE for Congenital Melanocytic Nevi

Not yet recruitingNCT04999631

Massachusetts General HospitalCongenital Melanocytic Nevus

Start: 2022-01-01End: 2028-01-01Target: 30Updated: 2021-10-28

Phase 1

Immune Response and General Immune Health in Subjects Infected With Herpes Simplex Virus Type 1 (HSV-1)

CompletedNCT03661541

Squarex, LLCHerpes Labialis, HSV

Start: 2017-03-02End: 2017-10-25Updated: 2021-11-03

Phase 2

A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis

TerminatedNCT03521479

Squarex, LLCHerpes Labialis, HSV

Start: 2018-03-12End: 2019-10-05Updated: 2021-08-06

Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation

RecruitingNCT05535738

Wei-Che KoAllergic Contact Dermatitis, Skin Inflammation

Start: 2022-11-15End: 2027-12-31Target: 45Updated: 2025-11-14